If you have plans to get FluMist nasal spray, you should not take any antiviral medication for at least two weeks, because the weakened flu virus will respond to the antivirals and ruin your ...

Since January 2024, pharmacists have been able to treat seven common health conditions without a prescription. The NHS have ...

A wide variety of COVID-19 symptoms exist, ranging from mild to severe, and while current strains of the virus generally ...

A wide variety of COVID-19 symptoms exist, ranging from mild to severe, and while current strains of the virus generally cause milder symptoms, those with co-morbidities are still at an exponentially ...

A new therapy may delay Alzheimer's disease progression by years, according to a study by researchers at Texas A&M University ...

More information: Christopher N. Vassallo et al, Anti-viral defence by an mRNA ADP-ribosyltransferase that blocks translation, Nature (2024). DOI: 10.1038/s41586-024-08102-8 ...

New research is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized treatment plans.

New research from Emory University reveals that nasal autoantibodies in COVID-19 patients may help predict disease severity, ...

Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...

An alternative, nasal spray, formulation has been developed that demonstrates good efficacy, high tolerability and a very fast onset of action. This study assessed the pharmacokinetics and ...

The companies’ monoclonal antibody met co-primary endpoints in a Phase III trial in patients with chronic rhinosinusitis with ...